Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years
Clinical trial NCT01777321 · COMPLETED
Trial details
- NCT number
- NCT01777321
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-17
- Primary completion
- 2013-10-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.